logo
logo

Lumicks Raises $93 Million In Series D Financing

Lumicks Raises $93 Million In Series D Financing

04/16/21, 9:40 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgamsterdam
Money raised
$93 million
Round Type
series d
LUMICKS, a leading, next-generation life science tools company that develops highly innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, announced the completion of a $93 million Series D preferred share financing.

Company Info

Company
Lumicks
Location
amsterdam, new york, united states
Additional Info
LUMICKS is a leading life science tools company that develops equipment for Dynamic Single-Molecule and Cell Avidity analysis, two rapidly emerging areas in biology research and immuno-oncology. Built upon innovative technologies, such as optical tweezers (Nobel Prize for Physics 2018) and STED super-resolution (Nobel Prize for Chemistry 2014), LUMICKS tools facilitate the understanding of life to the smallest detail.